Treated, hospital-onset Clostridiodes difficile infection: An evaluation of predictors and feasibility of benchmarking comparing 2 risk-adjusted models among 265 hospitals
Infection Control & Hospital Epidemiology · 2024
DOI: 10.1017/ice.2023.124 ↗Kurz gefasst
Fachartikel in der Zeitschrift Infection Control & Hospital Epidemiology, 2024. Verfasst von Kalvin C Yu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Becton, Dickinson and Company, Franklin Lakes, New Jersey. Hauptthemen laut MEDLINE: Clostridioides difficile, Cross Infection, Clostridium Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
To evaluate the incidence of a candidate definition of healthcare facility-onset, treated Clostridioides difficile (CD) infection (cHT-CDI) and to identify variables and best model fit of a risk-adjusted cHT-CDI metric using extractable electronic heath data.
Methods
We analyzed 9,134,276 admissions from 265 hospitals during 2015–2020. The cHT-CDI events were defined based on the first positive laboratory final identification of CD after day 3 of hospitalization, accompanied by use of a CD drug. The generalized linear model method via negative binomial regression was used to identify predictors. Standardized infection ratios (SIRs) were calculated based on 2 risk-adjusted models: a simple model using descriptive variables and a complex model using descriptive variables and CD testing practices. The performance of each model was compared against cHT-CDI unadjusted rates.
Results
The median rate of cHT-CDI events per 100 admissions was 0.134 (interquartile range, 0.023–0.243). Hospital variables associated with cHT-CDI included the following: higher community-onset CDI (CO-CDI) prevalence; highest-quartile length of stay; bed size; percentage of male patients; teaching hospitals; increased CD testing intensity; and CD testing prevalence. The complex model demonstrated better model performance and identified the most influential predictors: hospital-onset testing intensity and prevalence, CO-CDI rate, and community-onset testing intensity (negative correlation). Moreover, 78% of the hospitals ranked in the highest quartile based on raw rate shifted to lower percentiles when we applied the SIR from the complex model.
Conclusions
Hospital descriptors, aggregate patient characteristics, CO-CDI burden, and clinical testing practices significantly influence incidence of cHT-CDI. Benchmarking a cHT-CDI metric is feasible and should include facility and clinical variables.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Becton, Dickinson and Company, Franklin Lakes, New Jersey.
- Centers for Disease Control and Prevention, Atlanta, Georgia.
- Emory University School of Medicine, Atlanta, Georgia.
ORCID-Profile: Kalvin C Yu, Jonathan R Edwards, Raymund Dantes, Vikas Gupta, Kristina Betz
Zitieren
APA
Yu, K. C., Ye, G., Edwards, J. R., Dantes, R., Gupta, V., Ai, C., Betz, K., & Benin, A. L. (2024). Treated, hospital-onset Clostridiodes difficile infection: An evaluation of predictors and feasibility of benchmarking comparing 2 risk-adjusted models among 265 hospitals. Infection Control & Hospital Epidemiology. https://doi.org/10.1017/ice.2023.124
Vancouver
Yu KC, Ye G, Edwards JR, Dantes R, Gupta V, Ai C, et al. Treated, hospital-onset Clostridiodes difficile infection: An evaluation of predictors and feasibility of benchmarking comparing 2 risk-adjusted models among 265 hospitals. Infection Control & Hospital Epidemiology. 2024. doi:10.1017/ice.2023.124
BibTeX
@article{Yu2024,
author = {Yu, Kalvin C and Ye, Gang and Edwards, Jonathan R and Dantes, Raymund and Gupta, Vikas and Ai, ChinEn and Betz, Kristina and Benin, Andrea L},
title = {Treated, hospital-onset Clostridiodes difficile infection: An evaluation of predictors and feasibility of benchmarking comparing 2 risk-adjusted models among 265 hospitals},
journal = {Infection Control & Hospital Epidemiology},
year = {2024},
doi = {10.1017/ice.2023.124}
}
EUVIMED